Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06275282 · ClinicalTrials.gov registry record · NA
Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses
A NA study of Amputation and Prostheses and Implants, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT06275282: Recruiting NA study of Amputation and Prostheses and Implants, sponsored by University of Michigan.
NCT06275282 is a NA study of Amputation and Prostheses and Implants that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 3 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06275282, a NA study of Amputation and Prostheses and Implants, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals with an above-knee lower limb amputation are known to walk more slowly, expend more energy, have a greater risk of falling, and have reduced quality of life compared to individuals without amputation and those with below knee amputation. One of the driving factors behind these deficits is the lack of active function provided by above-knee prostheses with prosthetic knees and ankles. While many prosthetic devices have been developed for functional restoration after major lower extremity amputation, there remains no stable interface to facilitate reliable, long-term volitional control of an advanced robotic limb capable moving multiple joints. Moreover, there is no existing interface that provides useful sensory feedback that in turn enhances the functional capabilities of the prosthesis. To achieve both greater signal specificity and long-term signal stability, we have developed a biologic interface known as the Regenerative Peripheral Nerve Interface (RPNI). An RPNI consists of a peripheral nerve that is implanted into a free muscle graft that would otherwise go unused in the residual limb. As the nerve grows, it reinnervates the free muscle graft which undergoes a predictable sequence of revascularization and regeneration. The main questions it aims to answer are: 1. Can the amplitude, movement specificity and stability of sciatic nerve RPNI electromyography (EMG) signals be detected up to one year post RPNI surgery? 2. Do RPNIs contain information to enable control of a physical motorized prosthetic leg with multiple degrees of freedom? 3. Does stimulation of sciatic nerve RPNIs provides meaningful sensory feedback? Consenting participants with unilateral transfemoral amputation (TFA) will: 1. Undergo RPNI surgery and electrode implantation in the residual limb. 2. Attend regular follow-up visits following surgery to assess the health and signal strength of the RPNIs and their ability to use a prescribed prosthesis between 3- and 12-months followin
Primary Outcome
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity-Short Form 3a
Conditions Studied
Interventions
- DEVICE Intramuscular electrodes
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT06275282 shows while recruiting
NCT06275282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Intramuscular electrodes is the first listed.
NCT06275282 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06275282 about?
NCT06275282 is a clinical study titled "Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses". Individuals with an above-knee lower limb amputation are known to walk more slowly, expend more energy, have a greater risk of falling, and have reduced quality of life compared to individuals without amputation and those with below knee amputation. One of the driving factors behind these deficits i...
What is the current status of trial NCT06275282?
This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2025-02-13. Estimated completion is 2027-09-30.
What conditions does trial NCT06275282 study?
This clinical trial studies the following conditions: Amputation, Prostheses and Implants.
What interventions are being tested in trial NCT06275282?
The interventions under investigation include: Intramuscular electrodes (DEVICE).
Who is sponsoring clinical trial NCT06275282?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06275282 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06275282's enrollment target sits among peer trials
3 64th of 65 the lowest of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI